Skip to main content
. 2022 May 29;4(3):100205. doi: 10.1016/j.arrct.2022.100205

Fig 1.

Fig 1

Study schema: data will be collected at baseline, 8 weeks (when LLWS treatment ends), and then 8 and 16 weeks after treatment ends. The waitlist control will not receive treatment for 8 weeks, after which they will start LLWS and will be treated and assessed for a similar duration frequency as the treatment group.